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Abstract
Background: To assess the prevalence of laryngopharyngeal reflux (LPR) in the Greek general population and its
risk factors.
Methods: Questionnaire based epidemiological, adult participants’ survey. The Reflux Symptom Index (RSI) was
used for the assessment of LPR prevalence. The RSI questionnaire was completed by 340 (183 male and 157
female) randomly selected subjects. Subjects with RSI score ≥13 were considered as LPR patients and those with
RSI score <13 were considered as non LPR subjects.
Results: The prevalence of LPR in the general Greek population was found to be 18.8 % with no statistically
significant difference between the two genders (p > 0.05). The age group of 50–64 years showed the higher
prevalence rate. Tobacco smoking and alcohol consumption were found to be related with LPR. No reported
concomitant disease or medication was found to be related with LPR.
Conclusions: LPR prevalence in the Greek general population was found to be 18.8 %. Tobacco smoking and
alcohol consumption were found to be related with LPR.
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Background
LPR is defined as the retrograde movement of gastric
contents into the larynx and pharynx leading to a diver-
sity of upper aero digestive tract symptoms [1].
LPR has a significant negative impact on patient’s
quality of life [2]. LPR is an underdiagnosed entity in
otolaryngology and its actual prevalence and predispos-
ing factors in the community have not been established.
Potential risk factors and co-morbidities for LPR remain
unknown. Data concerning LPR prevalence in Greece
are lacking.
In 2002, Belafsky et al developed the Reflux Symptom
Index (RSI), a self-administered nine-item questionnaire,
designed to assess various symptoms related to LPR.
Each item is scaled from 0 (no problem) to 5 (severe
problem), with a maximum score of 45 indicating the
most severe symptoms. An RSI ≥ 13 is considered abnor-
mal and strongly indicative of LPR [3].
Since the introduction of RSI, many studies have
shown the reliability and consistency of the method in
various populations throughout the globe, establishing
the method as a very useful diagnostic tool in every day
practice [4–6]. Feng GJ et al have found that laryngo-
pharyngeal pH monitoring and RSI scoring have the
same value in diagnosing laryngopharyngeal reflux dis-
ease (LPRD) [7].
The primary aim of this study was to assess the preva-
lence of LPR in the general adult Greek population using
RSI as the diagnostic screening tool. Secondary aims of
the study were to identify any predisposing or associated
factors for developing LPR.
Methods
The study was carried out in the general Greek population
during the period from September to November 2013.
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A random sample (n = 1.000) of adults living in Athens
(500 people) and in rural Greek areas (500 people) was
initially approached through an “alert” telephone. During
the communication, the scope of the study was ex-
plained and permission to send the questionnaire to the
subjects’ address was obtained. The participants were
randomly selected through the telephone catalogue of
Athens City and telephone catalogues of randomly se-
lected rural areas using a Table of random numbers gener-
ated for the study. Five different investigators performed
the calls ten days before sending the questionnaire. Of the
1000 subjects who were approached, 450 accepted to par-
ticipate in the study and provided their personal details
(name - address). Only one person per family has to fill
the sent questionnaire. In the envelope that was sent to
the participants a more detailed explanation for the scope
of the study, detailed instructions for filling out the ques-
tionnaire, an informed consent and a prepaid envelope
were included, so that subjects could easily send back the
filled-in questionnaire as well as the signed informed con-
sent at no cost for them. Three hundred fifty individuals
returned the questionnaires (189 or 54 % from Athens
and 161 or 46 % from rural areas).
Data related to LPR symptoms were gathered through a
questionnaire containing the validated Greek version of
RSI. Additional questions concerning demographic data
(age and gender), behavioral characteristics (smoking sta-
tus and alcohol consumption) concomitant diseases and
concurrent medication were also included in the posted
questionnaire.
Inclusion criterion for our study was age since the
main scope of our study was to asses LPR prevalence in
the general adult population. In this regard, only sub-
jects >18 year old were included in the study. Subjects
with pre-existing gastro-esophageal reflux and those
taking anti-reflux medications were also included in
the study. Exclusion criteria for participation in the
study were current upper respiratory tract infections
and known laryngopharyngeal malignancies.
For the purpose of this study LPR diagnosis was based
on RSI score ≥ 13 as proposed by Belafsky et al [3].
The study protocol was approved by the Scientific
Committee and Review Board of Athens Speech,
Language and Swallowing Institute. Informed consent was
obtained from all participants prior to inclusion in the
study.
Statistical tests were performed using the IBM SPSS
Statistics 20 software.
Variables of the analysis were: Demographic parame-
ters, smoking and alcohol habits, health background
(concomitant diseases), concomitant medication and the
reflux symptom index.
The independent samples of Student’s test were used
to compare the RSI values in the patients with LPR
and in subjects without LPR which were used as con-
trol group.
The study sample size was calculated based on the as-
sumption that LPR prevalence is higher than 15 %
Statistical tests used for the statistical analysis were:
– Significance level for all hypothesis testing (p-value)
was 0.05
– Correlations between the levels of the RSI were
performed using the Spearman’s Rho correlation
coefficient test.
– The prevalence of LPR was estimated using a
minimum cut-off score of ≥ 13 on the RSI as
proposed by Belafski et al. [3]
We assessed the prevalence of LPR in the general
Greek population using the RSI. In this regard, the
Greek version of the validated RSI questionnaire was
given to 450 subjects from different parts of Greece
(50 % from urban areas and 50 % from rural areas) to be
completed. Eventually 350 completed questionnaires
were collected.
Results
The questionnaire was given to 450 subjects. Three hun-
dred and fifty subjects (response rate 77.8 %) returned
completed questionnaires. In 10 out of the 350 returned
questionnaires, critical information like gender and age
were lacking. Thus 340 (183 male and 157 female) duly
completed questionnaires were appropriate for statistical
analysis. Demographic data and patients’ behavioral
characteristics are shown in Table 1. The mean age of
the participants was 46.86 ± 14.54 years. Most partici-
pants belonged to the age group of 35–49 (131 subjects)
while the age groups > 80 and < 20 were poorly repre-
sented (3 subjects > 80 year and 2 subjects < 20 year).
One hundred seventy four (51.2 %) participants were
smokers with mean number of cigarettes per day 20.5 and
mean duration of smoking 18.23 ± 8.6 years for male and
17.02 ± 8.0 years for female, with no statistically significant
difference between the two genders (t-test >0,05).
One hundred and one subjects (29.7 %) drank alcohol
regularly (68.3 % male and 31.7 % female). Mean alcohol
consumption per day was 2.43 ± 1.62 units for males and
2.17 ± 1.32 units for females with no statistical signifi-
cance between the two genders (t-test > 0.05). The most
commonly reported alcoholic drinks were wine (30)
followed by beer (21) and whisky (18).
One hundred forty two (41.8 %) participants reported
one or more diseases. The reported diseases were: cardio-
vascular 50 (35.2 %), gastrointestinal 25 (17.6 %), musculo-
skeletal 15 (10.6 %), respiratory 10 (7.0 %), thyroidopathy
9 (6.3 %), anemia 3 (2.1 %) and other diseases 30 (21.1 %).
Among the reported gastrointestinal diseases, 5 cases were
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gastroesophageal reflux disease (GERD), 13 dyspepsia, 5
gastritis and 2 duodenal ulcers.
One hundred and thirty seven (40.3 %) participants re-
ported use of one or more medication for the concomitant
diseases. The reported medications were: antihypertensive
43 (31.4 %), anticholesterol 19 (13.9 %), antiulcerants 19
(13.9 %), [15 PPIs (proton pump inhibitors) and 4 H2 an-
tagonists], antidiabetics 11 (8.0 %), anti-asthmatics/COPD
(chronic obstructive pulmonary disease) 11 (8.0 %),
antihypothyroidism 9 (6.6 %), antiosteoporotics 7 (5.1 %)
[5 calcium carbonate and 2 bisphosphonates], non ster-
oidal anti-inflammatory drugs 4 (1,2 %) and other medica-
tions 18 (13.1 %).
Two hundred sixty six subjects (78.2 %) reported one
or more symptoms included in the RSI. The most com-
monly reported symptoms were No 9 “Heartburn, chest
pain, indigestion, or stomach acid coming up” (52 %)
and No 2 “Clearing your throat” (48.2 %) (Table 2).
Sixty four subjects (18.8 %) out of the 340 participants
of our study presented an RSI ≥13 and were considered as
patients with LPR, compared to 276 subjects with an
RSI < 13 who were considered to be subjects without
LPR. The mean RSI score in patients with LPR was
24.8 ± 8.0 compared to the subjects without LPR the
mean RSI of which was 2.3 ± 3.2 (p < 0.001) (Table 3).
Spearman’s Rho correlations analysis showed that all
the pairs between the 9 items of the RSI were correlated,
meaning that if a subject responded positively to one
item there was a high probability to respond positively
to the other item.
Based on the findings of our study the prevalence of
LPR in the Greek general population was found to be
18.8 %. The LPR prevalence for males was 19.7 % and
for females 17.8 % with no statistically significant differ-
ence between the two genders (t-test, p > 0.05).
Most subjects with LPR (RSI ≥13) belonged to the age
groups of 50–64 year (40.6 %) and 35–49 (34.4 %).
These two age groups represented 75 % of the LPR cases
encountered in the general Greek population. No LPR
cases reported in ages >80 and <20 but this may be due
to the very small sample size of these two particular age
groups.
Statistical analysis did not show any relation between
LPR and any of the reported diseases nor LPR and
Table 1 Demographic data and behavioral characteristics of
study participants
Variable Group Number Percent
Gender Female 157 46.2
Male 183 53.8
Total 340 100.0







> = 80 3 0.9
Total 340 100.0
Smoking Yes 174 51.2
No 166 48.8
Total 340 100
Duration of smoking (years)









Number of cigarettes per day









Drinker No 239 70.3
Yes 101 29.7
Total 340 100





Table 2 Frequency of reported symptoms included in reflux
symptom index by the participants of the study
Symptom Number Percent
1. Hoarseness or a problem with your voice 131 38,5
2. Clearing your throat 164 48,2
3. Excess throat mucus or postnasal drip 130 38,2
4. Difficulty swallowing food, liquids, or pills 99 29,1
5. Coughing after you ate or after lying down 110 32,3
6. Breathing difficulties or choking episodes 108 31,8
7. Troublesome or annoying cough 105 30,9
8. Sensation of something sticking in your throat
or a lump in your throat
138 40,6
9. Heartburn, chest pain, indigestion, or stomach
acid coming up
177 52
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reported medications (Chi-square test > 0.05 for both
cases). The lack of such findings has to be accepted with
reservations and not as conclusive due to the limited
number of reported diseases and medications, and since
the primary aim of this study was not to assess these
two parameters.
A correlation was found between LPR and smoking and
alcohol consumption. Factor analysis was used to assess a
potential association between the Factor’s Score and the
information available for every person. It was concluded
that alcohol drinkers and nondrinkers have a statistically
significant difference in their mean factor score, as well as
smokers compared to nonsmokers (t-test, p-value < 0.001
and p-value = 0.006 respectively. The direction of this as-
sociation is shown in the box plots (Figs. 1 and 2).
We should be aware that the smokers of this study
tend to consume alcohol more often than non-smokers.
For that reason we cannot be sure which of the two, to-
bacco or alcohol consumption has an effect on increas-
ing the average score of the RSI.
Discussion
LPR remains a controversial topic with inconsistent data
concerning its epidemiology, etiology, diagnosis and man-
agement [8].
It is difficult to estimate the prevalence of LPR in the
general population since there is not an easy and gener-
ally accepted diagnostic method available for large scale
epidemiological studies [9]. It has been reported that up
to 10 % of patients presenting to an otolaryngologist’s
Table 3 Mean score and standard deviation of the reflux symptom index items in patients with LPR and in non LPR subjects
Group RSI1 RSI2 RSI3 RSI4 RSI5 RSI6 RSI7 RSI8 RSI9 Total RSI
LPR
Mean 3,1598 3,6201 2,8217 1,8081 2,1246 3,1041 1,9204 2,8788 3,3224 24,76
SD 1,2624 1,5578 1,1601 1,3196 1,4513 1,3143 1,4723 1,1786 1,5923 8,0032
Non LPR
Mean 0,2218 0,3832 0,4689 0,2125 0,1987 0,0989 0,1375 0,3137 0,2718 2,3207
SD 0,3726 0,4576 0,7238 0,3806 0,9086 0,8076 0,7178 0,4463 0,6534 3,2261
P valueLPR vs Non LPR <0,001 < 0,001 < 0,001 < 0,001 < 0,001 < 0,001 < 0,001 < 0,001 < 0,001 < 0,001
RSI1: Hoarseness or a problem with your voice, RSI2: Clearing your throat, RSI3: Excess throat mucus or postnasal drip, RSI4: Difficulty swallowing food, liquids, or
pills, RSI5: Coughing after eating or after lying down, RSI6: Breathing difficulties or choking episodes, RSI7: Troublesome or annoying cough, RSI8: Sensations of
something sticking in your throat or a lump in your throat, RSI9: Heartburn, chest pain, indigestion, or stomach acid coming up
Fig. 1 Box-plot of RSI factor score between smokers and non smokers
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office and more than 50 % of patients with hoarseness
are patients with reflux related disease [10, 11]. LPR epi-
sodes have been reported by 30–50 % of the normal
control [12, 13] and the prevalence of LPR in the general
population has been reported to vary between 7.1 % [14]
to 64 % [9]. The big difference in the reported LPR
prevalence is mainly attributed to the differences in the
methods used by each investigator as well as to the ab-
sence of a generally adopted definition of LPR.
The need for an easily administered and generally ac-
cepted diagnostic method for early detection of LPR pa-
tients is crucial, considering that LPR is better at
predicting the presence of esophageal adenocarcinoma
than typical gastroesophageal reflux symptoms [15], and
that LPR is related to laryngopharyngeal carcinoma [16].
There is not a reliable known prevalence of LPR symp-
toms in the Greek population and thus the objectives of
this study were to use a validated tool, the RSI in Greek,
to identify LPR symptoms.
In this study subjects scoring RSI ≥ 13 are presumed to
be LPR patients and those with RSI < 13 were presumed
to be LPR free subjects.
According to the findings of this study, the prevalence
of LPR in the general Greek population was found to be
18.8 %. No significant difference was observed between
males and females in the prevalence of LPR. The age
group where LPR prevalence was reported more fre-
quently was 50–64 (40.2 %). Lowden et al demonstrated
that 26.5 % of patients attending a general practice in
UK had an RSI >10 [17]. Kamani T et al. have shown
that 30 % of the UK general population have an RSI > 10
[18]. A study conducted in Greece using the RSI as a
diagnostic tool for LPR has found the prevalence of LPR
to be 8.5 % in the Greek population. However, that study
did not refer to the general population since the partici-
pants were mainly ambulatory patients who were visiting
primary care centers for various chronic diseases or pa-
tients’ escorts [19]. Another drawback of the previously
mentioned study was the exclusion of subjects with cer-
tain diseases like irritable bowel syndrome (IBS), peptic
ulcer disease, major psychiatric illnesses and those using
non steroidal anti-inflammatory drugs (NSAIDs), condi-
tions that are all well known to have a higher LPR preva-
lence [18, 20]. In addition, the gender make-up was not
well balanced and male participants represented only
36.3 % of the study population vs 63.7 % female. Al-
though this study did not find a significant difference in
LPR prevalence between men and women in agreement
with finding from other studies [18, 21], some other in-
vestigators have found LPR prevalence to be much
higher in males [22, 23]. The different LPR prevalence
rate obtained by the above mentioned studies, which
used RSI as diagnostic tool for LPR diagnosis, reflects
the different methodology each investigator used regard-
ing LPR definition and population selection.
It is important to mention the high frequency of LPR
related symptoms reported by the participants of our
study. Two hundred sixty out of the total 340 (78.2 %)
Fig. 2 Box-plot of RSI factor score between drinkers and non drinkers
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reported one or more symptom included in the RSI.
Most common reported symptoms were RSI9 “Heart-
burn, chest pain, indigestion, or stomach acid coming
up” (52 %) and RSI2 “Clearing your throat” (48.2 %).
The high frequency of RSI9, especially in the middle
aged people of the general population, is also in line with
the findings of other investigators [18, 24].
No relation between LPR and reported diseases nor
LPR and medication was found. However these findings
could not be considered as conclusive due to the small
number of reported concomitant diseases and to the
small number of medications.
A correlation was found between LPR and smoking
and alcohol consumption. Lin CC et al reported a cor-
relation between total RSI and smoking as well as alco-
hol drinking with certain RSI items [4]. Kamani T et al
did not find any association between LPR related
symptoms and smoking or alcohol consumption [18].
It should be noted that in our study the smokers tend
to consume alcohol more often than non-smokers.
That’s why we cannot be sure which of the two, smok-
ing or alcohol habits, has an effect on increasing the
average score of the RSI nor which causes the other.
Kamani T et al have found alcohol not to be a risk fac-
tor for LPR-related symptoms [18]. Controversy re-
garding the effect of alcohol exists not only for LPR,
but also for GERD, as the results of different studies
are diverse and contradictory. Despite the controver-
sies regarding the effect of smoking and drinking on
LPR, the recommendation of lifestyle modifications for
the treatment of LPR include smoking cessation and
limiting alcohol intake [25].
To the best of our knowledge, our study is the first
that has been designed to assess the prevalence of LPR
in the general population using the RSI score of ≥13 as
the criterion for LPR diagnosis. Similar studies coming
from different countries and populations can give us a
more clear view on LPR prevalence. So that the findings
of future studies are comparable we propose the cut-off
point of RSI ≥13 to be the base for LPR diagnosis and
the sample to refer to pure general population.
A limitation of this study could be the lack of com-
parison between the applied method and a method with
higher specificity (flexible endoscopy or ambulatory 24-h
double-probe pH monitoring), but on one hand these
methods are invasive and costly and are not suitable for
large scale epidemiological studies and on the other
hand this comparison has already been done in other
studies and has proved similar validity of the two
methods [7]. Another limitation of the study could be
the small sample size of concomitant diseases and medi-
cations that did not permit us to reach a confident con-
clusion regarding the relationship between LPR and the
above mentioned factors.
Conclusions
LPR prevalence in the general Greek population assessed
by RSI was found to be 18.8 %. Tobacco smoking and al-
cohol consumption were found to be related with LPR.
RSI is an easy and useful tool in daily clinical practice
not only for the diagnosis and management of LPR but
also for epidemiological studies.
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